CMSCX vs. NCLEX

Last updated Jun 3, 2026

CMSCX (Columbia Small Cap Growth Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, CMSCX returned 17.15%/yr vs 7.33%/yr for NCLEX. Their correlation of 0.89 suggests significant overlap in exposure. CMSCX charges 0.96%/yr vs 0.85%/yr for NCLEX.

Performance

CMSCX vs. NCLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Columbia Small Cap Growth Fund (CMSCX) and Nicholas Limited Edition Fund (NCLEX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CMSCX achieves a 22.77% return, which is significantly higher than NCLEX's -5.61% return. Over the past 10 years, CMSCX has outperformed NCLEX with an annualized return of 17.15%, while NCLEX has yielded a comparatively lower 7.33% annualized return.

CMSCX

• 1D: -0.17%
• 1M: 8.37%
• YTD: 22.77%
• 6M: 21.96%
• 1Y: 57.73%
• 3Y*: 26.79%
• 5Y*: 7.17%
• 10Y*: 17.15%

NCLEX

• 1D: 1.62%
• 1M: 1.92%
• YTD: -5.61%
• 6M: -5.60%
• 1Y: -10.19%
• 3Y*: 1.08%
• 5Y*: -0.92%
• 10Y*: 7.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CMSCX vs. NCLEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CMSCX Columbia Small Cap Growth Fund	22.77%	21.68%	24.27%	26.17%	-36.62%	-2.22%	70.31%	40.98%	-1.99%	28.68%
NCLEX Nicholas Limited Edition Fund	-5.61%	-10.41%	11.91%	17.17%	-23.71%	19.07%	22.67%	27.36%	-0.94%	19.93%

Correlation

The correlation between CMSCX and NCLEX is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.66
Correlation (3Y) Calculated over the trailing 3-year period	0.80
Correlation (5Y) Calculated over the trailing 5-year period	0.87
Correlation (10Y) Calculated over the trailing 10-year period	0.88
Correlation (All Time) Calculated using the full available price history since Oct 1, 1996	0.89

Over the past year, the correlation between CMSCX and NCLEX has dropped to 0.66 - well below their long-term average of 0.89, suggesting their price drivers have been diverging.

Return for Risk

CMSCX vs. NCLEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CMSCX

CMSCX Risk / Return Rank: 63
CMSCX Sharpe Ratio Rank: 69
CMSCX Sortino Ratio Rank: 54
CMSCX Omega Ratio Rank: 50
CMSCX Calmar Ratio Rank: 73
CMSCX Martin Ratio Rank: 71

NCLEX

NCLEX Risk / Return Rank: 1
NCLEX Sharpe Ratio Rank: 1
NCLEX Sortino Ratio Rank: 1
NCLEX Omega Ratio Rank: 1
NCLEX Calmar Ratio Rank: 1
NCLEX Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CMSCX vs. NCLEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Columbia Small Cap Growth Fund (CMSCX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CMSCX	NCLEX	Difference
Sharpe ratio Return per unit of total volatility	2.43	-0.64	+3.07
Sortino ratio Return per unit of downside risk	3.10	-0.81	+3.91
Omega ratio Gain probability vs. loss probability	1.39	0.91	+0.48
Calmar ratio Return relative to maximum drawdown	3.34	-0.50	+3.84
Martin ratio Return relative to average drawdown	13.77	-1.05	+14.82
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CMSCX vs. NCLEX - Sharpe Ratio Comparison

The current CMSCX Sharpe Ratio is 2.43, which is higher than the NCLEX Sharpe Ratio of -0.64. The chart below compares the historical Sharpe Ratios of CMSCX and NCLEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CMSCX	NCLEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.43	-0.64	+3.07
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.27	-0.05	+0.31
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.66	0.38	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	0.52	0.00

Drawdowns

CMSCX vs. NCLEX - Drawdown Comparison

The maximum CMSCX drawdown since its inception was -55.64%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for CMSCX and NCLEX.

Drawdown Indicators

	CMSCX	NCLEX	Difference
Max Drawdown Largest peak-to-trough decline	-55.64%	-48.68%	-6.96%
Max Drawdown (1Y) Largest decline over 1 year	-17.60%	-21.36%	+3.76%
Max Drawdown (3Y) Largest decline over 3 years	-28.41%	-28.50%	+0.09%
Max Drawdown (5Y) Largest decline over 5 years	-49.84%	-28.50%	-21.34%
Max Drawdown (10Y) Largest decline over 10 years	-52.44%	-35.79%	-16.65%
Current Drawdown Current decline from peak	-0.83%	-21.03%	+20.20%
Average Drawdown Average peak-to-trough decline	-15.95%	-8.28%	-7.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.26%	10.16%	-5.90%

Volatility

CMSCX vs. NCLEX - Volatility Comparison

Columbia Small Cap Growth Fund (CMSCX) has a higher volatility of 7.78% compared to Nicholas Limited Edition Fund (NCLEX) at 5.09%. This indicates that CMSCX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CMSCX	NCLEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.78%	5.09%	+2.69%
Volatility (6M) Calculated over the trailing 6-month period	19.13%	12.11%	+7.02%
Volatility (1Y) Calculated over the trailing 1-year period	24.52%	16.92%	+7.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.05%	19.52%	+7.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.90%	19.21%	+6.69%

CMSCX vs. NCLEX - Expense Ratio Comparison

CMSCX has a 0.96% expense ratio, which is higher than NCLEX's 0.85% expense ratio.

Dividends

CMSCX vs. NCLEX - Dividend Comparison

CMSCX's dividend yield for the trailing twelve months is around 4.01%, less than NCLEX's 7.98% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CMSCX Columbia Small Cap Growth Fund	4.01%	4.93%	0.00%	0.00%	0.00%	10.28%	6.90%	8.86%	21.17%	16.48%	8.67%	60.38%
NCLEX Nicholas Limited Edition Fund	7.98%	7.53%	2.51%	2.43%	6.22%	16.44%	5.10%	5.66%	10.72%	7.97%	10.68%	8.05%

Frequently Asked Questions

Can I hold both CMSCX and NCLEX in my portfolio?

CMSCX and NCLEX have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CMSCX or NCLEX?

CMSCX has higher volatility (7.78%) compared to NCLEX (5.09%). In terms of maximum drawdown, CMSCX dropped -55.64% vs NCLEX's -48.68%.

Which has better risk-adjusted returns?

CMSCX currently has the higher Sharpe Ratio (2.43 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.